(Q39588345)

13 September 2017

title

An orally available small imidazolium salt ameliorates inflammation and fibrosis in a murine model of cholestasis (English)

1 reference

13 September 2017

1 reference

Zhaobing Ding

1

1 reference

13 September 2017

Yinling Kng

2

1 reference

13 September 2017

Henry Yang

3

1 reference

13 September 2017

Zhiyuan Ke

4

1 reference

13 September 2017

Lang Zhuo

5

1 reference

13 September 2017

publication date

21 February 2011

1 reference

13 September 2017

published in

Laboratory Investigation

1 reference

13 September 2017

volume

91

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

752-763

1 reference

Mechanisms of hepatic fibrogenesis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

CCR2 promotes hepatic fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Matrix metalloproteinase gene delivery for liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

A class of imidazolium salts is anti-oxidative and anti-fibrotic in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

A novel normalization method for effective removal of systematic variation in microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Liver fibrosis: cellular mechanisms of progression and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Attenuated liver fibrosis in the absence of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Functional role of chemokines in liver disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

inferred from DOI database lookup

7 January 2021

based on heuristic

The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

inferred from DOI database lookup

7 January 2021

based on heuristic

Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.11

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2011.11

1 reference

13 September 2017

1 reference